1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
Biotech stocks often present intriguing, and potentially very lucrative, investment opportunities. Share prices can explode on positive trial results or key regulatory approvals.
According to top analysts on the Street, these five “Strong Buy” biotech stocks are primed for outsized growth in the next 12 months.
Biotechs often present intriguing, and potentially...
Check out our weekly earnings calendar and read the latest quarterly earnings previews.
More Investing News »